Apixaban and rivaroxaban are both factor Xa inhibitors.
Your search for apixaban returned 4 results
Asundexian is an investigational oral Factor XIa inhibitor.
Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.
Andexxa was granted accelerated approval by the FDA in May 2018.